PACS Group, Inc. is a prominent technology solutions provider dedicated to improving operational efficiency across various sectors through innovative software and hardware systems. The company prioritizes research and development to leverage emerging technological trends and drive digital transformation initiatives. With a strong portfolio of strategic collaborations and a solid market presence, PACS Group is well-positioned for sustainable growth, making it an attractive investment proposition for institutional investors seeking to participate in the rapidly evolving technology landscape.
| Revenue (TTM) | $5.55B |
| Gross Profit (TTM) | $961.21M |
| EBITDA | $478.30M |
| Operating Margin | 7.66% |
| Return on Equity | 27.90% |
| Return on Assets | 4.60% |
| Revenue/Share (TTM) | $35.34 |
| Book Value | $7.01 |
| Price-to-Book | 6.34 |
| Price-to-Sales (TTM) | 1.26 |
| EV/Revenue | 1.824 |
| EV/EBITDA | 21.08 |
| Quarterly Earnings Growth (YoY) | 51.60% |
| Quarterly Revenue Growth (YoY) | 9.10% |
| Shares Outstanding | $158.34M |
| Float | $47.85M |
| % Insiders | 69.50% |
| % Institutions | 31.47% |
Volatility is currently expanding
The consensus price target hints at a 25.7% upside potential for PACS Group, Inc. (PACS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
PACS Group, Inc. (PACS) Q2 2026 Earnings Call Transcript
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the second quarter of 2026. Second Quarter 2026 Financial Highlights Revenue was $1.43 billion, an increase of 9.1% over prior year. Net income was $76.3 million, an increase of $25.4 million, or 49.8% from $51.0 million in the prior-year period. Diluted Earnings.
Investors interested in Medical Services stocks are likely familiar with PACS Group, Inc. (PACS) and Alignment Healthcare (ALHC). But which of these two companies is the best option for those looking for undervalued stocks?
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) announced today that it intends to report its financial results for the second quarter ended June 30, 2026, on Tuesday, August 4, 2026, after the stock market closes. Management will host a call on Wednesday, August 5, 2026, at 11:30 a.m. ET to discuss the financial results and related information.PACS Group invites current and prospective investors to listen to the call via webcast by going to the Investors.
PHILADELPHIA--(BUSINESS WIRE)--Investor litigation firm Kaskela Law announces that it is investigating PACS Group, Inc. (NYSE: PACS) (“PACS”) on behalf of the company's long-term investors. Click here for additional information: https://kaskelalaw.com/case/pacs-group/ Recently a federal securities fraud complaint was filed against PACS on behalf of certain investors who purchased shares of the company's stock between April 11, 2024 and December 16, 2024 (the “Wrongdoing Period”). According to t.
Investors with an interest in Medical Services stocks have likely encountered both PACS Group, Inc. (PACS) and Alignment Healthcare (ALHC). But which of these two stocks presents investors with the better value opportunity right now?
SAN DIEGO, July 14, 2026 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that a lawsuit is currently pending for certain investors in PACS Group, Inc. (NYSE: PACS) shares. NOTICE: Investors who purchased shares of PACS Group, Inc. (NYSE: PACS) prior to April 2024 and continue to hold any of those NYSE: PACS shares have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) announced today that subsidiaries of the Company have entered into a definitive agreement to acquire the operations of 34 skilled nursing facilities across six western states from Eduro Healthcare (“Eduro”), a family-owned company with a nearly 20-year history of caring for seniors. The operations are in Texas (22 facilities), Montana (six facilities), South Dakota (three facilities), and one facility in each of New Mexico, North Da.
REYKJAVIK, Iceland--(BUSINESS WIRE)--Varist today introduced its DICOM Detection Engine™, a specialized system designed to safeguard healthcare communications networks, electronic health records (EHR) and picture archiving and communication systems (PACS) used in medical imaging from malware, including AI-powered malware that employs artificial intelligence to automate, scale and customize cyberattacks. The Varist malware detection engine combines large-scale file scanning with real-time simula.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on PACS and any ticker you trade — then tracks every position and per-strategy win rate.
